This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Product Information
CONCERTA ER 36 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $13.0452 per EA under NDC 50458058601. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 1, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Methylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
36 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458058601
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021121FDA Approved
8/1/2000
TE Code
AB
On Market Since
8/1/2000
Pharmacological Classes
Price Statistics
The NADAC for CONCERTA ER 36 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 80.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.0452 per EA |
|---|---|
| All-time high | $13.0800 (Nov 15, 2023) |
| All-time low | $7.2344 (Nov 28, 2013) |
| 52-week high | $13.0619 |
| 52-week low | $13.0409 |
| Median price | $11.9653 |
| Average price | $11.2930 |
| Largest weekly change | +9.9% (Jan 13, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CONCERTA ER 36 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CONCERTA ER 36 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $13.0452 per EA (NDC 50458058601), effective Aug 19, 2026.
How has the price of CONCERTA ER 36 MG TABLET changed over time?
Over the history we have for it, the NADAC for CONCERTA ER 36 MG TABLET has risen 80.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CONCERTA ER 36 MG TABLET?
Since Nov 28, 2013, the NADAC for CONCERTA ER 36 MG TABLET has ranged from a low of $7.2344 (Nov 28, 2013) to a high of $13.0800 (Nov 15, 2023), with a median of $11.9653 per EA.
Are there cheaper alternatives to CONCERTA ER 36 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE ER 36 MG TAB, is $0.6665 per EA — about 95% below CONCERTA ER 36 MG TABLET.
Who manufactures CONCERTA ER 36 MG TABLET?
CONCERTA ER 36 MG TABLET (NDC 50458058601) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Is CONCERTA ER 36 MG TABLET in shortage?
Yes — NDC 50458058601 is currently listed in FDA's drug shortage database (posted Jul 26, 2023).